Virtus ETF Advisers LLC X Biotech Inc. Transaction History

Virtus ETF Advisers LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$10.95 - $16.07 $157,942 - $231,793	-14,424 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$12.95 - $18.24 $13,960 - $19,662	1,078 Added 8.08%	14,424 $187,000
Q2 2021 Aug 10, 2021	SELL	$15.83 - $17.84 $39,986 - $45,063	-2,526 Reduced 15.91%	13,346 $221,000
Q1 2021 May 17, 2021	BUY	$15.92 - $20.3 $4,584 - $5,846	288 Added 1.85%	15,872 $273,000
Q4 2020 Feb 12, 2021	SELL	$15.65 - $19.92 $118,814 - $151,232	-7,592 Reduced 32.76%	15,584 $244,000
Q3 2020 Nov 13, 2020	SELL	$13.97 - $21.16 $44,201 - $66,950	-3,164 Reduced 12.01%	23,176 $442,000
Q2 2020 Aug 05, 2020	BUY	$10.39 - $16.07 $85,665 - $132,497	8,245 Added 45.57%	26,340 $361,000
Q1 2020 May 14, 2020	SELL	$8.89 - $24.94 $23,469 - $65,841	-2,640 Reduced 12.73%	18,095 $192,000
Q4 2019 Feb 13, 2020	BUY	$8.33 - $19.95 $172,722 - $413,663	20,735 New	20,735 $387,000

4.87M

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $194M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.